# Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

> **NCT01755416** · PHASE2 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 18 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Closed loop with sensor and Insulin
- **DRUG:** Closed loop with sensor, Insulin and Liraglutide

## Key facts

- **NCT ID:** NCT01755416
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755416, "Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01755416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*